ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2022 American Transplant Congress

June 4-8, 2022 in Boston, MA

The ATC program is built in the Eastern Time Zone.

View by Title View Sessions View Topics
View by Date

Sunday, June 5, 2022

5:40pm-5:50pm
Achievement of Persistent Mixed Chimerism in Recipients of Matched and Mismatched Living Donor Kidney Transplants in a Tolerance Induction Protocol

J. D. Scandling, S. Busque, R. Lowsky, T. Pham, R. Hoppe, K. Jensen, A. Shori, H. Wu, R. Pawar, E. Engleman, E. Meyer, S. Strober

Immunosuppression and Tolerance: Preclinical and Translational Studies  •  Hynes Ballroom A
5:40pm-5:50pm
Allograft TLR9 is Required for Endogenous Donor-Reactive Memory CD8 T Cell Activation in High-Risk Cardiac Allografts to Mediate CTLA-4Ig Resistant Graft Rejection

E. H. Koritzinsky, D. Ueda, H. Tsuda, S. Miyari, R. L. Fairchild

Innate Immunity, Chemokines, Cytokines, and Complement  •  Hynes Room 309
5:40pm-5:50pm
Autologous Mesenchymal Stem Cells for Treatment of Chronic Antibody-Mediated Kidney Graft Rejection: Report of the First Phase I/II Clinical Case Series

Ž. Večerić-Haler1, M. Sever2, N. Kojc3, G. Mlinšek1, M. Oblak1, P. Halloran4, A. Aleš Rigler1, J. Buturović Ponikvar1, M. Arnol5

Cellular/Islet Therapies and Tissue Engineering  •  Hynes Room 310
5:40pm-5:50pm
Cost-Effectiveness of Transplanting Hepatitis C Donor Hearts Into Hepatitis C Uninfected Recipients

A. R. Gandhi1, A. E. Woolley2, L. R. Baden2, M. M. Givertz2, M. L. Jones1, J. Kim3, H. R. Mallidi2, M. R. Mehra2, A. M. Neilan1

Heart and VADs: All Topics I  •  Hynes Room 210
5:40pm-5:50pm
Development and Validation of a Medication Safety Dashboard in Veteran Transplant Recipients: Preliminary Results of a Multicenter Cluster-Randomized Controlled Clinical Trial

D. Taber1, R. Felkner2, K. Rife3, D. Cooney3, S. Laforest3, E. Santa4, N. Super5, C. Hall6, T. Goddard1, R. Alexander1

Non-Organ Specific: Clinical Pharmacy/Transplant Pharmacotherapy  •  Hynes Room 312
5:40pm-5:50pm
Digital Spatial Profiling of Kidney Allograft Biopsies with Chronic Allograft Dysfunction in African American Transplant Recipients

C. R. Dorr1, S. A. Elmer1, B. Wu2, B. Guo2, J. Czyzyk2, G. Crary3, G. Onyeaghala1, W. Oetting2, P. Jacobson2, R. B. Mannon4, G. Agarwal5, J. Maltzman6, A. Matas2, A. Israni3

Kidney Complications: Chronic Antibody Mediated Rejection & Immune Mediated Late Graft Failure  •  Hynes Room 302
5:40pm-5:50pm
Donor Derived Transmissions 2020: Analysis of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC) with a Focus on COVID-19

R. M. La Hoz1, A. Agarwal1, G. Berry1, K. Dunn1, J. Goldman1, S. Ho1, M. Kittleson1, D. H. Lee1, D. J. Levine1, C. Marboe1, G. Marklin1, S. Pouch1, R. Razonable1, S. Taimur1, H. Te1, A. Woolley1, C. Fox2, C. Jett2, S. Booker2, D. K. Klassen2, L. Danziger-Isakov1

COVID-19 Infections Part 1: All Organs  •  Hynes Ballroom B
5:40pm-5:50pm
Early Outcomes for Liver Transplant with Thoracoabdominal Normothermic Regional Perfusion for Donation After Circulatory Death: A Multi-Center Experience

A. L. Brubaker1, A. Lee1, B. Jackson1, J. Berumen1, J. R. Parekh1, K. L. Mekeel1, A. R. Gupta2, J. M. Gardner2, T. Chaly3, A. K. Mathur4, C. Jadlowiec4, K. Reddy4, R. Nunez4, J. Bellingham5, E. Thomas6, J. R. Wellen7, M. Kearns1, V. Pretorius1, G. T. Schnickel1

Surgery innovative Techniques Including Living Donor  •  Hynes Room 313
5:40pm-5:50pm
Pre-Emptive Rituximab to Prevent Post Transplant Lymphoproliferative Disorder (PTLD) in Pediatric Kidney Transplant Recipients with EBV DNAemia: A Case Series from the Pediatric Nephrology Research Consortium (PNRC)

I. Ashoor1, S. Ranabothu2, S. Al-Akash3, A. Moudgil4, Y. Shi4, S. Kizilbash5, D. Puliyanda6, V. Dharnidharka7

Kidney: Pediatrics  •  Hynes Ballroom C
5:40pm-5:50pm
Prediction of ESRD Risk in Living Kidney Donors Through Thirty Years Post-Donation

A. Massie1, J. Snyder2, M. Levan1, D. Brennan1, F. Al-Ammary1, D. Segev1

Kidney Living Donor: Long Term Outcomes  •  Hynes Room 206
  • «Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 54
  • Next Page»

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences